560
W. Qian et al. / Tetrahedron 62 (2006) 556–562
Anal. Calcd for C17H31BF4N3O2: C 51.53, H 7.89, N 10.60.
Found: C 51.15, H 7.96, N 10.62.
6H), 1.24 (s, 6H), 1.53 (t, 3J(H,H)Z11.2 Hz, 2H), 1.90–1.94
(m, 2H), 3.90 (s, 3H), 5.02–5.08 (m, 1H), 5.21 (s, 2H), 7.71
(s, 2H), 9.05 (s, 1H); 13C NMR (DMSO-d6, ppm): dZ20.7,
32.3, 36.3, 43.6, 49.9, 58.6, 69.3, 1237, 124.1, 138.1, 166.8;
IR (KBr): nZ2978, 2940, 1753, 1580, 1467, 1225, 1179,
1061 cmK1; MS (ESI): m/z (%): 98 (68.2) [C5H8NOC], 82
(46.2) [C4H6N2C], 55 (94.3) [C4H7C], 41 (100.0) [C2H3NC].
Anal. Calcd for C15H25BF4N3O3: C 47.14, H 6.59, N 10.99.
Found: C 46.86, H 6.76, N 10.63.
4.2.4. 1,3-Bis(4-(2,2,6,6-tetramethyl-1-oxyl-4-piper-
idoxyl)butyl)imidazolium tetrafluoroborate. To a suspen-
sion of 0.245 g (3.6 mmol) of imidazole and 0.7 g potassium
carbonate in acetone (10 mL) was added 1.84 g (6 mmol) of
4-(2,2,6,6-tetramethyl-1-oxyl-4-piperidoxyl)butyl bromide,
and the mixture was stirred under the refluxing for 48 h. And
then 0.396 g (3.6 mmol) NaBF4 was added to the mixture to
continue stirring for 72 h. The sodium bromide precipitate
was removed by filtration and the filtrate concentrated by
rotary evaporation. The yield was 1.50 g (82%), red viscous
4.3. General procedure for alcohol oxidations
[dibmim]C[BF4]K (353 mg, 0.6 mmol) was added to a
solution of alcohol (0.5 mmol) in 1.5 g of water containing
5% mmol of ion-supported TEMPO. The reaction mixture
was stirred at 30 8C for a given time. The mixture was
extracted with ether (3!8 mL) and concentrated under
reduced pressure. The filtrate could be reused for next run
after the oxidant in reduced form was removed by filtration.
The product was purified by flash column chromatography
using petroleum ether and Et2O as eluent. All products were
commercially available and identified by comparison of the
isolated products with authentic samples.
1
oil; H NMR (DMSO-d6, ppm): dZ1.04 (s, 12H), 1.07 (s,
12H), 1.22–1.26 (m, 4H), 1.37–1.42 (m, 4H), 1.70–1.76 (m,
4H), 1.82–1.86 (m, 4H), 3.37 (t, 3J(H,H)Z6.4 Hz, 4H),
3
3.48–3.52 (m, 2H), 3.96 (t, J(H,H)Z7.2 Hz, 4H), 7.61 (s,
2H), 8.96 (s, 1H); 13C NMR (DMSO-d6, ppm): dZ20.9,
27.0, 28.1, 30.0, 32.5, 32.8, 45.0, 46.2, 56.2, 58.3, 67.0,
68.9, 70.3, 119.6, 129.1, 137.6; IR (KBr): nZ2973, 2935,
2871, 1510, 1464, 1363, 1147, 1108 cmK1; MS (ESI): m/z
(%): 141 (43.2) [C9H19NC], 124 (100.0) [C9H1C6]. Anal.
Calcd for C29H53BF4N4O4: C 57.24, H 8.78, N 9.21. Found:
C 56.95, H 8.96, N 9.52.
1
4.3.1. Benzaldehyde. Oil; H NMR (CDCl3, ppm): dZ
4.2.5. 2,2,6,6-Tetramethyl-1-oxyl-4-piperidinyl 2-chloro-
acetate. To a solution of 4.3 g (0.025 mol) 4-hydroxy-
TEMPO and 3.11 g (0.0275 mol) 2-chloroacetyl chloride in
dichloromethane (30 mL) was slowly added 2.18 g
(0.0275 mol) of pyridine under cooling, and the mixture
was standing over night. The precipitate was removed by
filtration and the filtrate was washed with water (30 mL),
10% NaHCO3, then 2 mol dilute HCl and finally water
(30 mL). The solution was dried over Na2SO4 and
concentrated under vacuum to give red solid 4.98 g
7.52–7.56 (m, 2H; Ar-H), 7.62–7.65 (m, 1H; Ar-H),
7.88–7.90 (m, 2H; Ar-H), 10.03 (s, 1H; CHO); IR (neat):
nZ1703 cmK1 (C]O); MS (70 eV): m/z (%): 106 (100)
[MC], 105 (94) [MCKH], 77 (92) [C6HC5 ].
4.3.2. 4-Methoxybenzaldehyde. Oil; 1H NMR (CDCl3,
ppm): dZ3.90 (s, 3H; CH3), 7.01 (d, 3J(H,H)Z7.6 Hz, 2H;
3
Ar-H), 7.85 (d, J(H,H)Z7.6 Hz, 2H; Ar-H), 9.89 (s, 1H;
CHO); IR (neat): nZ1685 cmK1 (C]O); MS (70 eV): m/z
(%): 136 (76) [MC], 135 (100) [MCKH].
1
(80%). Mp: 49–51 8C; H NMR (CDCl3, ppm): dZ1.22
(s, 6H), 1.25 (s, 6H), 1.68 (t, 3J(H,H)Z11.6 Hz, 2H),
1.94–1.98 (m, 2H), 4.02 (s, 2H), 5.11–5.16 (m, 1H); 13C
NMR (CDCl3, ppm): dZ20.4, 31.8, 41.0, 43.5, 59.2, 69.1,
166.8; IR (KBr): nZ2978, 2954, 1753, 1464, 1319, 1177,
1136 cmK1; MS (ESI): m/z (%): 248 (14.5) [MC], 250 (5.2)
[MCC2], 124 (53.9) [C9H1C6], 109 (100), 41 (82.3). Anal.
Calcd for C11H19ClNO3: C 53.12, H 7.70, N 5.63. Found: C
52.99, H 7.73, N 5.54.
4.3.3. 4-Chlorobenzaldehyde. Mp: 46–47 8C; 1H NMR
3
(CDCl3, ppm): dZ7.53 (d, J(H,H)Z8.4 Hz, 2H; Ar-H),
7.83 (d, 3J(H,H)Z8.4 Hz, 2H; Ar-H), 9.99 (s, 1H; CHO); IR
(KBr): nZ1702 cmK1 (C]O); MS (70 eV): m/z (%): 139
(100) [MC], 141 (33) [MCC2].
4.3.4. Furaldehyde. Oil; 1H NMR (CDCl3, ppm): dZ
6.61–6.63 (m, 1H), 7.27–7.30 (m, 1H), 7.70–7.71 (m, 1H),
9.67 (s, 1H; CHO); IR (neat): nZ1675 cmK1 (C]O); MS
(70 eV): m/z (%): 96 (100) [MC], 95 (94) [MCKH], 39 (58)
[C3HC3 ].
4.2.6. 1-Methyl-3-(2-oxo-2-(2,2,6,6-tetramethyl-1-oxyl-4-
piperidoxyl)ethyl)imidazolium chloride. (This procedure
is similar to the preparation of bromide above). Mp:
1
225–227 8C; H NMR (DMSO-d6, ppm): dZ1.08 (s, 6H),
4.3.5. Cinnamaldehyde. Oil; 1H NMR (CDCl3, ppm): dZ
1.11 (s, 6H), 1.51 (t, 3J(H,H)Z11.6 Hz, 2H), 1.88–1.94 (m,
2H), 3.92 (s, 3H), 5.02–5.07 (m, 1H), 5.28 (s, 2H), 7.77 (s,
2H), 9.22 (s, 1H); 13C NMR (DMSO-d6, ppm): dZ20.7,
32.5, 36.3, 43.8, 49.9, 58.4, 69.3, 123.7, 124.1, 138.1, 166.9;
3
6.73 (dd, J(H,H)Z8.0, 15.6 Hz, 1H; CH), 7.44–7.45 (m,
3H; Ar-H), 7.49 (d, 3J(H,H)Z15.6 Hz, 1H; CH), 7.56–7.58
(m, 2H; Ar-H), 9.71 (d, 3J(H,H)Z8.0 Hz, 1H; CH); IR
(neat): nZ1679 cmK1 (C]O); MS (70 eV): m/z (%): 132
(73) [MC], 131 (100) [MCKH], 103 (56) [C8HC7 ].
IR (KBr): nZ2977, 1747, 1633, 1464, 1223, 1177 cmK1
;
MS (ESI): m/z (%): 124 (34.3) [C6H8N2OC], 82 (100.0)
[C4H6NC2 ], 56 (85.1) [C2H4N2C], 55 (91.2) [C4HC7 ], 42
(84.2) [C2H4NC]. Anal. Calcd for C15H25ClN3O3: C 54.46,
H 7.62, N 12.70. Found: C 54.44, H 7.75, N 12.61.
4.3.6. Ethyl 4-formylbenzoate. Mp: 156–158 8C; 1H NMR
(CDCl3, ppm): dZ1.43 (t, 3J(H,H)Z6.4 Hz, 3H; CH3), 4.42
3
3
(q, J(H,H)Z6.4 Hz, 2H; CH2), 7.96 (d, J(H,H)Z8.4 Hz,
3
4.2.7. 1-Methyl-3-(2-oxo-2-(2,2,6,6-tetramethyl-1-oxyl-4-
piperidoxyl)ethyl)imidazolium tetrafluoroborate. (This
procedure is similar to the preparation of tetrafluoroborate
2H; Ar-H), 8.21 (d, J(H,H)Z8.4 Hz, 2H; Ar-H), 10.11 (s,
1H; CHO); IR (KBr): nZ3058, 2981, 2924, 1711, 1274,
1102, 733 cmK1; MS (70 eV): m/z (%): 178 (3.3) [MC], 149
(100) [C9H9OC2 ].
1
above). Red oil; H NMR (DMSO-d6, ppm): dZ1.15 (s,